Ahmed A. Kousba, Ph.D.

Associate Director, Pharmacokinetics
Bioagilytix San Diego

Poster(s):

• (W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
  Wednesday, October 23, 2024

  9:30 AM – 10:30 AM MT

• (M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
  Monday, October 21, 2024

  9:30 AM – 10:30 AM MT

• (T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
  Tuesday, October 22, 2024

  10:30 AM – 11:30 AM MT

• (M1130-02-11) Toxicokinetics of cNP8, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
  Monday, October 21, 2024

  11:30 AM – 12:30 PM MT

• (T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
  Tuesday, October 22, 2024

  12:30 PM – 1:30 PM MT

• (M1330-02-11) Toxicokinetics of cP12, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
  Monday, October 21, 2024

  1:30 PM – 2:30 PM MT